# KLAYESTA
> **ANDA210532** · Abbreviated New Drug Application (Generic) · Sponsor: EPIC PHARMA LLC · Approved 2018-04-30
## Drug
- **FDA Application Number:** ANDA210532
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** KLAYESTA
- **Generic name:** NYSTATIN TOPICAL POWDER
- **Active ingredients:** NYSTATIN
- **Dosage form:** POWDER
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** EPIC PHARMA LLC
- **Manufacturer:** Epic Pharma, LLC
- **First approval:** 2018-04-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210532)
---
*AI Analytics · CC0 1.0*